Lifespan can be extended by a drug therapy up to 38% in a future
Data of scientific researches, published in the journal Nature show that treated old mice with rapamycin it extended their expected lifespan by up to 38%. Rapamycin is already used to prevent organ rejection in transplant patients, and in stents implanted into patients to keep their coronary arteries open. It is also being tested as a possible treatment for cancer.
Researchers at three centres in Texas, Michigan and Maine gave the drug to mice at an age equivalent to 60 in humans.
The mice were bred to mimic the genetic diversity and susceptibility to disease of humans as closely as possible.
Rapamycin extended the animals' expected lifespan by between 28% and 38%.
The researchers estimated that in human terms this would be greater than the predicted increase in extra years of life, if both cancer and heart disease were prevented and cured.
But 'Don't try it now. In no way should anyone consider using this particular drug to try to extend their own lifespan, as rapamycin suppresses immunity.